Novo Nordisk receives approval for Victoza® in Japan
- Details
- Category: Novo Nordisk
Novo Nordisk announced that the Japanese Ministry of Health, Labour and Welfare has approved Victoza® for the treatment of type 2 diabetes. Victoza® is the brand name for liraglutide, the first Glucagon-Like Peptide-1 (GLP-1) analogue approved in Japan, developed for the treatment of type 2 diabetes.
Sanofi-aventis and employees unite for the victims of Haiti
- Details
- Category: Sanofi
In the face of the unprecedented earthquake that hit the island of Haiti, sanofi-aventis has committed 1 million Euros in financial aid to long-term reconstruction initiatives and the rehabilitation of the population of Haiti.
Three new Novartis medicines approved in Japan
- Details
- Category: Novartis
Patients in Japan will benefit from the approval of three new Novartis medicines - Equa® (vildagliptin), marketed as Galvus® in the European Union, for the treatment of type 2 diabetes, Exforge® (valsartan/amlodipine) for high blood pressure, and Afinitor® (everolimus) for advanced kidney cancer. These approvals reinforce the strong commitment of Novartis to helping patients in Japan, the company's second-largest pharmaceutical market.
Bristol-Myers Squibb supporting efforts to help survivors
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb is joining the world community in providing immediate help for survivors of the massive earthquake that struck Haiti on January 12. The company has already shipped a large donation of antibiotics through Project Hope, an organization providing direct relief to disaster victims.
Lilly Sends Relief to Haiti Earthquake Victims
- Details
- Category: Eli Lilly and Company
Eli Lilly and Company (NYSE: LLY) will provide donations of medicines and money for victims of the catastrophic earthquake in Haiti on January 12. Lilly has initially pledged $250,000 in direct cash contributions.
Abbott Increases Aid to $2.5 Million for Haiti Relief and Recovery Efforts
- Details
- Category: Abbott
Working directly with humanitarian partners to help address the growing health care crisis, Abbott (NYSE: ABT) is expanding its support for relief efforts in Haiti. The company will provide $2.5 million in grant funding and donations of critical pharmaceutical and nutritional products to humanitarian aid organizations.
Novartis providing equivalent of over USD 2.5 million for victims of Haiti earthquake
- Details
- Category: Novartis
Through its local organizations in countries throughout the region, Novartis is providing the equivalent of over USD 2.5 million in immediate emergency aid for victims of the recent earthquake in Haiti. The support includes both direct financial aid to relief agencies working in Haiti as well as donations of essential medicines, including antibiotic and pain relieving drugs.
More Pharma News ...
- Amgen Donates $2 Million, Establishes Earthquake Relief Program
- Abbott to Provide $1 Million in Funding, Products to Help Address Health Needs in Haiti
- Novo Nordisk starts phase 1 trial with long-acting oral GLP-1 analogue
- FDA approves ACTEMRA for the treatment of moderately to severely active rheumatoid arthritis
- Genzyme Reports Fourth-Quarter Revenue
- Novartis launches schizophrenia treatment Fanapt in the US
- Abbott's XIENCE V(R) Approved in Japan - Second Largest Drug Eluting Stent Market Worldwide